These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
87 related items for PubMed ID: 7293181
1. [Chemotherapy of non-Hodgkin lymphoma by the COP schedule]. Krajewska B, Solska E, Dziewulska-Bokiniec A. Wiad Lek; 1981 May 15; 34(10):815-9. PubMed ID: 7293181 [No Abstract] [Full Text] [Related]
2. [Results of treatment of advanced cases of non-Hodgkin's-lymphoma (author's transl)]. Kotlarek-Haus S, Nowicka J, Gabryś K, Starzyk H, Becker M, Kaiser A, Hinrle Z. Przegl Lek; 1979 May 15; 36(7):567-71. PubMed ID: 504706 [No Abstract] [Full Text] [Related]
3. [VCP therapy for non-Hodgkin's lymphoma advanced more than stage IIB]. Kuraishi Y, Ozeki H, Takasaki N, Mashizu N, Nagamine D, Usui N, Yamazaki H, Nakamura T, Aiba K, Yokoyama K. Rinsho Ketsueki; 1984 Nov 15; 25(11):1731-7. PubMed ID: 6543455 [No Abstract] [Full Text] [Related]
4. A comparative study with COP and COP-Bleo combination chemotherapy in advanced (non-Hodgkin's) lymphomas. Kaku K, Inoue M, Fujii S, Ishida Y, Hiroshige Y, Shinohara K, Nakashima K, Matsumoto N, Kaneko T. Nihon Ketsueki Gakkai Zasshi; 1983 Jul 15; 46(4):940-6. PubMed ID: 6195877 [No Abstract] [Full Text] [Related]
5. Evaluation of two combination chemotherapies in previously untreated non Hodgkin's lymphoma. Somoza N, Pavlovsky S, Suárez A, Morgenfeld M, Besuschio SC, Bezares R, Quiroga Micheo E, Lein JM, De María H. Medicina (B Aires); 1981 Jul 15; 41 Suppl():35-43. PubMed ID: 7345350 [No Abstract] [Full Text] [Related]
7. [Preliminary analysis of results of chemotherapy in patients with proliferative disease of the lymphatic system with the exclusion of Hodgkin's disease using vincristine, cyclophosphamide and prednisone]. Zelechowska JA, Leszczyk C, Madej G, Pieńkowska F, Nozdryn-Plotnicki B. Pol Tyg Lek; 1977 Aug 22; 32(34):1329-31. PubMed ID: 905177 [No Abstract] [Full Text] [Related]
8. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma]. Hayashi T, Takahashi T, Mihara M, Shimizu H, Tsukuda H, Kobayashi T, Adachi M, Hinoda Y, Aoki S, Mori M, Tsujisaki M, Imai K. Gan To Kagaku Ryoho; 1997 May 22; 24(7):889-91. PubMed ID: 9170532 [No Abstract] [Full Text] [Related]
10. [Polychemotherapy of lymphosarcoma by the COP program]. Abdullaev RA, Poddubnaia IV, Shramko AF. Sov Med; 1984 May 22; (7):103-6. PubMed ID: 6385297 [No Abstract] [Full Text] [Related]
11. [Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients]. Izumi T, Muroi K, Hoshino Y, Komatsu N, Ohtsuki T, Yamada M, Tomizuka H, Hatake K, Furusawa S, Miura Y. Gan To Kagaku Ryoho; 1996 May 22; 23(6):797-800. PubMed ID: 8645033 [No Abstract] [Full Text] [Related]
13. [Present status and future problems in non-Hodgkin's lymphoma. III. On the chemotherapy of non-Hodgkin's lymphoma (author's transl)]. Sakano T. Rinsho Ketsueki; 1981 Feb 22; 22(2):159-77. PubMed ID: 7031290 [No Abstract] [Full Text] [Related]
14. [Clinical analysis of 282 patients with non-Hodgkin's lymphoma]. Chen SP, Wu DS, Zhao XL. Hunan Yi Ke Da Xue Xue Bao; 2003 Jun 22; 28(3):237-9. PubMed ID: 14653077 [Abstract] [Full Text] [Related]
17. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma. Wilder RB, Rodriguez MA, Ha CS, Pro B, Hess MA, Cabanillas F, Cox JD. Cancer; 2001 Jun 15; 91(12):2440-6. PubMed ID: 11413536 [Abstract] [Full Text] [Related]